# Evommune, Inc. (EVMN) Evommune, Inc. (EVMN) stock surges over 70% on positive Phase 2a atopic dermatitis data, with analysts highlighting potential 'best-in-class' efficacy and durability. ### About Evommune, Inc. Evommune, Inc. is a biotechnology company focused on developing therapies for chronic inflammatory diseases. Evommune, Inc. uses the ticker $EVMN for trading. Listed in the [Stocks](/list/stocks) category. ### Insights - Evommune, Inc. (EVMN) market dominance near a 52-week high at [-------]. - Evommune, Inc. (EVMN) trading volume is up 5819.58% from the previous month. - Evommune, Inc. (EVMN) market cap is up 89.12% from the previous week. - Evommune, Inc. (EVMN) social dominance is up 1561.54% from the previous month. - Evommune, Inc. (EVMN) Galaxy Scoreβ’ is up 74.07% from the previous week. - Evommune, Inc. (EVMN) creators is up 981.54% from the previous week. - Evommune, Inc. (EVMN) engagements is up 2468.72% from the previous week. - Evommune, Inc. (EVMN) mentions is up 404.4% from the previous week. - Evommune, Inc. (EVMN) posts created is up 2048.15% from the previous week. - Evommune, Inc. Creators hit a 52-Week high of [---] for the day - Evommune, Inc. Creators hit an all time of [---] for the day - Evommune, Inc. Mentions hit a 52-Week high of [---] for the day - Evommune, Inc. Mentions hit an all time of [---] for the day - Evommune, Inc. entered the top [--] AltRankβ’ for the first time - Evommune, Inc. Price hit a 52-Week high of $32.60 for the hour - Evommune, Inc. Price hit an all time of $32.60 for the hour - Evommune, Inc. Engagements hit a 52-Week high of [-------] for the day - Evommune, Inc. Engagements hit an all time of [-------] for the day ### Price: $31.60  [Price 24-Hour Time-Series Raw Data](/topic/evommune-inc/time-series/close.tsv) The stock price has seen a significant surge, hitting a 52-week and all-time high, driven by positive Phase 2a data for EVO301 and a substantial increase in social media buzz, creator activity, and mentions. 24-Hour: 15.32% 7-Day: 82.38% 30-Day: 87.92% 1-Year High: $31.60 on 2026-02-13 1-Year Low: $15 on 2025-12-18 ### AltRank: [---]  [AltRank 24-Hour Time-Series Raw Data](/topic/evommune-inc/time-series/alt_rank.tsv) Evommune, Inc. (EVMN) is currently AltRank #356 based on combined combined social and market metrics Daily Average: [-----] [--] Week: [---] +326 1-Year High: [-----] on 2026-02-05 1-Year Low: [--] on 2026-02-10 ### Galaxy Score: [-----]  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/evommune-inc/time-series/galaxy_score.tsv) Current Value: [-----] Daily Average: [--] [--] Week: [--] +20 1-Year High: [--] on 2026-02-10 1-Year Low: [--] on 2026-02-05 ### Engagements: [------] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/evommune-inc/time-series/interactions.tsv) Current Value: [------] Daily Average: [-----] [--] Week: [-------] +2,469% [--] Month: [-------] +634% 1-Year High: [-------] on 2026-02-10 1-Year Low: [--] on 2025-12-13 Engagements by network (24h): Reddit: [--] TikTok: [--] X: [------] YouTube: [--] ### Mentions: [---] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/evommune-inc/time-series/posts_active.tsv) Current Value: [---] Daily Average: [--] [--] Week: [-----] +404% 1-Year High: [---] on 2026-02-11 1-Year Low: [--] on 2025-02-16 Mentions by network (24h): Reddit: [--] TikTok: [--] X: [---] YouTube: [--] ### Creators: [---] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/evommune-inc/time-series/contributors_active.tsv) [---] unique social accounts have posts mentioning Evommune, Inc. (EVMN) in the last [--] hours which is down 37% from [---] in the previous [--] hours Daily Average: [--] [--] Week: [---] +982% 1-Year High: [---] on 2026-02-11 1-Year Low: [--] on 2025-02-16 The most influential creators that mention Evommune, Inc. in the last [--] hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@doepke_michel](/creator/twitter/doepke_michel) | [--] | [------] | [--] | [-----] | | [@HOThomasWPhelps](/creator/twitter/HOThomasWPhelps) | [--] | [-----] | [--] | [-----] | | [@BPharmCatalyst](/creator/twitter/BPharmCatalyst) | [--] | [------] | [--] | [-----] | | [@ElSheikh_Stock](/creator/twitter/ElSheikh_Stock) | [--] | [-----] | [--] | [---] | | [@JoseRestonVA](/creator/twitter/JoseRestonVA) | [--] | [-----] | [--] | [---] | | [@DekmarTrades](/creator/twitter/DekmarTrades) | [--] | [-------] | [--] | [---] | | [@zohmbastic](/creator/twitter/zohmbastic) | [--] | [------] | [--] | [---] | | [@BioStocks](/creator/twitter/BioStocks) | [--] | [------] | [--] | [---] | | [@TopStockAlerts1](/creator/twitter/TopStockAlerts1) | [--] | [-------] | [--] | [---] | | [@hassytrades](/creator/twitter/hassytrades) | [--] | [------] | [--] | [--] | [View More](/list/creators/evommune-inc/100) ### Sentiment: 90%  [Sentiment 24-Hour Time-Series Raw Data](/topic/evommune-inc/time-series/sentiment.tsv) Current Value: 90% Daily Average: 82% [--] Week: 100% no change [--] Month: 87% +12% 1-Year High: 100% on 2025-10-10 1-Year Low: 33% on 2025-11-29 Most Supportive Themes: - Creator Activity Surge: (38%) Evommune, Inc. has seen a significant increase in active creators, reaching a 52-week and all-time high. - Mention Volume Spike: (177%) Mentions of Evommune, Inc. have also hit a 52-week and all-time high, indicating increased public interest. Most Critical Themes: - Social Dominance Increase: (749%) Evommune, Inc.'s social dominance has surged significantly, far exceeding its daily average. ### Social Dominance: 0.021%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/evommune-inc/time-series/social_dominance.tsv) Current Value: 0.021% Daily Average: 0.00538% [--] Week: 0.02% +0.018% [--] Month: 0.022% +0.02% 1-Year High: 0.083% on 2026-02-11 1-Year Low: 0.0001% on 2025-09-25 ### Market Dominance: 0.00115%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/evommune-inc/time-series/market_dominance.tsv) Current Value: 0.00115% Daily Average: 0% 1-Year High: 0.00116% on 2026-02-13 1-Year Low: 0.00061% on 2026-02-09 ### Market Cap: $1,013,499,590  [Market Cap 24-Hour Time-Series Raw Data](/topic/evommune-inc/time-series/market_cap.tsv) Current Value: $1,013,499,590 Daily Average: $638,219,592 [--] Week: $1,013,499,590 +89% [--] Month: $995,215,616 +61% 1-Year High: $995,215,616 on 2026-02-13 1-Year Low: $525,191,389 on 2026-02-05 ### Top Evommune, Inc. Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "Another strong trading week. While $ICHR (+35.80%) stole the show $LUXE $FGL $EVMN and $CODA provided steady gains. $AP $HVT.A $ABP $SHOP $JNJ $WISH and $QCOM added some excellent depth. Data-driven discipline always drives these results. Enjoy your weekend coffee.π" [X Link](https://x.com/JustinMorganQ8/status/2022679626594791593) [@JustinMorganQ8](/creator/x/JustinMorganQ8) 2026-02-14T14:29Z [---] followers, [---] engagements "𧬠Weekly & YTD Biotech Moves Week ending 02/13/26 $XBI: -2.11% ($122.86) π΄ $IBB: -1.39% ($172.55) π΄ Year-to-date $XBI: 0.76% π’ $IBB: 2.24% π’ See image below. π 𧬠Biotech Weekly News Largest single-day stock moves during the week ending 02/13/26 π $EVMN 71% EVO301 Topline data $NKTR 51% REZOLVE-AD Maintenance Data $HUMA 30% New Defense Funding for Blood Vessels $PHIO 24% Positive SMC wrap-up on PH-762 $NVCR 19% FDA Approves Optune https://t.co/RjwPL6kU1b 𧬠Biotech Weekly News Largest single-day stock moves during the week ending 02/13/26 π $EVMN 71% EVO301 Topline data $NKTR 51%" [X Link](https://x.com/BiopharmIQ/status/2022674375322018086) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-02-14T14:08Z 28.9K followers, [----] engagements "𧬠Biotech Weekly News Largest single-day stock moves during the week ending 02/13/26 π $EVMN 71% EVO301 Topline data $NKTR 51% REZOLVE-AD Maintenance Data $HUMA 30% New Defense Funding for Blood Vessels $PHIO 24% Positive SMC wrap-up on PH-762 $NVCR 19% FDA Approves Optune Pax for Cancer π $UPB -47% VALIANT Trial Results $MCRB -42% Program and Corporate Updates $CHRS -20% Pricing of Public Offering $1.75/sh $OKYO -19% Pricing of $20M Offering $1.85/sh $RGNX -14% Regulatory Update on RGX-121 BLA See image below. *** AD momentum continues. $NKTR maintenance data + early Ph2a from $EVMN in a" [X Link](https://x.com/BiopharmIQ/status/2022672827145650554) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-02-14T14:02Z 28.9K followers, [----] engagements "@JoseRestonVA Understand π«‘ Just saw you added a couple of AD names with $KYMR $APGE $CRVS $EVMN" [X Link](https://x.com/tradingsssss/status/2022487921216069890) [@tradingsssss](/creator/x/tradingsssss) 2026-02-14T01:47Z [----] followers, [---] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Evommune, Inc. (EVMN) stock surges over 70% on positive Phase 2a atopic dermatitis data, with analysts highlighting potential 'best-in-class' efficacy and durability.
Evommune, Inc. is a biotechnology company focused on developing therapies for chronic inflammatory diseases.
Evommune, Inc. uses the ticker $EVMN for trading. Listed in the Stocks category.
Price 24-Hour Time-Series Raw Data
The stock price has seen a significant surge, hitting a 52-week and all-time high, driven by positive Phase 2a data for EVO301 and a substantial increase in social media buzz, creator activity, and mentions.
24-Hour: 15.32% 7-Day: 82.38% 30-Day: 87.92%
1-Year High: $31.60 on 2026-02-13
1-Year Low: $15 on 2025-12-18
AltRank 24-Hour Time-Series Raw Data
Evommune, Inc. (EVMN) is currently AltRank #356 based on combined combined social and market metrics
Daily Average: [-----]
[--] Week: [---] +326
1-Year High: [-----] on 2026-02-05
1-Year Low: [--] on 2026-02-10
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +20
1-Year High: [--] on 2026-02-10
1-Year Low: [--] on 2026-02-05
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [-----]
[--] Week: [-------] +2,469%
[--] Month: [-------] +634%
1-Year High: [-------] on 2026-02-10
1-Year Low: [--] on 2025-12-13
Engagements by network (24h): Reddit: [--] TikTok: [--] X: [------] YouTube: [--]
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [--]
[--] Week: [-----] +404%
1-Year High: [---] on 2026-02-11
1-Year Low: [--] on 2025-02-16
Mentions by network (24h): Reddit: [--] TikTok: [--] X: [---] YouTube: [--]
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Evommune, Inc. (EVMN) in the last [--] hours which is down 37% from [---] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] +982%
1-Year High: [---] on 2026-02-11
1-Year Low: [--] on 2025-02-16
The most influential creators that mention Evommune, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @doepke_michel | [--] | [------] | [--] | [-----] |
| @HOThomasWPhelps | [--] | [-----] | [--] | [-----] |
| @BPharmCatalyst | [--] | [------] | [--] | [-----] |
| @ElSheikh_Stock | [--] | [-----] | [--] | [---] |
| @JoseRestonVA | [--] | [-----] | [--] | [---] |
| @DekmarTrades | [--] | [-------] | [--] | [---] |
| @zohmbastic | [--] | [------] | [--] | [---] |
| @BioStocks | [--] | [------] | [--] | [---] |
| @TopStockAlerts1 | [--] | [-------] | [--] | [---] |
| @hassytrades | [--] | [------] | [--] | [--] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 90%
Daily Average: 82%
[--] Week: 100% no change
[--] Month: 87% +12%
1-Year High: 100% on 2025-10-10
1-Year Low: 33% on 2025-11-29
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.021%
Daily Average: 0.00538%
[--] Week: 0.02% +0.018%
[--] Month: 0.022% +0.02%
1-Year High: 0.083% on 2026-02-11
1-Year Low: 0.0001% on 2025-09-25
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00115%
Daily Average: 0%
1-Year High: 0.00116% on 2026-02-13
1-Year Low: 0.00061% on 2026-02-09
Market Cap 24-Hour Time-Series Raw Data
Current Value: $1,013,499,590
Daily Average: $638,219,592
[--] Week: $1,013,499,590 +89%
[--] Month: $995,215,616 +61%
1-Year High: $995,215,616 on 2026-02-13
1-Year Low: $525,191,389 on 2026-02-05
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Another strong trading week. While $ICHR (+35.80%) stole the show $LUXE $FGL $EVMN and $CODA provided steady gains. $AP $HVT.A $ABP $SHOP $JNJ $WISH and $QCOM added some excellent depth. Data-driven discipline always drives these results. Enjoy your weekend coffee.π"
X Link @JustinMorganQ8 2026-02-14T14:29Z [---] followers, [---] engagements
"𧬠Weekly & YTD Biotech Moves Week ending 02/13/26 $XBI: -2.11% ($122.86) π΄ $IBB: -1.39% ($172.55) π΄ Year-to-date $XBI: 0.76% π’ $IBB: 2.24% π’ See image below. π 𧬠Biotech Weekly News Largest single-day stock moves during the week ending 02/13/26 π $EVMN 71% EVO301 Topline data $NKTR 51% REZOLVE-AD Maintenance Data $HUMA 30% New Defense Funding for Blood Vessels $PHIO 24% Positive SMC wrap-up on PH-762 $NVCR 19% FDA Approves Optune https://t.co/RjwPL6kU1b 𧬠Biotech Weekly News Largest single-day stock moves during the week ending 02/13/26 π $EVMN 71% EVO301 Topline data $NKTR 51%"
X Link @BiopharmIQ 2026-02-14T14:08Z 28.9K followers, [----] engagements
"𧬠Biotech Weekly News Largest single-day stock moves during the week ending 02/13/26 π $EVMN 71% EVO301 Topline data $NKTR 51% REZOLVE-AD Maintenance Data $HUMA 30% New Defense Funding for Blood Vessels $PHIO 24% Positive SMC wrap-up on PH-762 $NVCR 19% FDA Approves Optune Pax for Cancer π $UPB -47% VALIANT Trial Results $MCRB -42% Program and Corporate Updates $CHRS -20% Pricing of Public Offering $1.75/sh $OKYO -19% Pricing of $20M Offering $1.85/sh $RGNX -14% Regulatory Update on RGX-121 BLA See image below. *** AD momentum continues. $NKTR maintenance data + early Ph2a from $EVMN in a"
X Link @BiopharmIQ 2026-02-14T14:02Z 28.9K followers, [----] engagements
"@JoseRestonVA Understand π«‘ Just saw you added a couple of AD names with $KYMR $APGE $CRVS $EVMN"
X Link @tradingsssss 2026-02-14T01:47Z [----] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$evmn